BauerA. W.: Antibiotic susceptibility testing by a standardized single disk method. Amer. J. Clin. Pathol., 45; 493 (1966).
2.
HardingS. M.: The comparative pharmacokinetics of ceftazidime and cefotaxime in healthy volunteers. J. Antimicr. Chemother., 8; 263 (1981).
3.
HardingS. M.: Pharmacokinetics of ceftazidime in normal subjects. J. Antimicr. Chemother., 8; 261 (1981).
4.
HarperP. B.: The in vitro properties of ceftazidime. J. Antimicr. Chemother., 8; 5 (1981).
5.
LennetteE. H.: Manual of clinical microbiology.American Society for Microbiology, Washington D.C.1980.
6.
MondorfA. W.: Assessment of the nephrotoxic potential of ceftazidime and ceftazidime-tobramycin combination in volunteers. Infection, 11; 57 (1983).
7.
MoutonR. P.: Susceptibility of ceftazidime and other cephalosporins to a range of betalactames and their potential as inducing agents. J. Antimicr. Chemother., 8; 147 (1981).
8.
VanhoofR.: The in vitro activity of ceftazidime: comparison with other beta-lactamase antibiotics. J. Antimicr. Chemother., 8; 63 (1981).
